Rosen, a leading law firm, encourages immunitybio, inc. investors with losses to secure counsel before important august 29 deadline in securities class action - ibrx

New york , aug. 14, 2023 /prnewswire/ --  why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of immunitybio, inc. (nasdaq: ibrx) between may 23, 2022 and may 10, 2023, both dates inclusive (the "class period"), of the important august 29, 2023 lead plaintiff deadline. so what: if you purchased immunitybio securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
IBRX Ratings Summary
IBRX Quant Ranking